• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

US-Derived ICU Mortality Model Holds Up in China, but Only After Recalibration

by
October 29, 2026
in Health, Technology
Reading Time: 3 mins read
0
US-Derived ICU Mortality Model Holds Up in China, but Only After Recalibration

US-Derived ICU Mortality Model Holds Up in China, but Only After Recalibration

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A mortality prediction model built for ICU patients with bloodstream infection can travel from a US database to a Chinese hospital, but only after a statistical tune-up, according to a new study published in BMC Medical Informatics and Decision Making. The research, led by Yinting Zhu, Wen Song and colleagues with senior author Qiongfang Zhu, tested whether a deliberately simple five-variable model developed on American data could still identify high-risk patients in a Chinese tertiary teaching hospital.

The team built their 30-day mortality model using MIMIC-IV, a widely used intensive care database containing 1,501 patients with bloodstream infection. The result was a parsimonious model relying on five predictors that are routinely available in almost any ICU: age, the 24-hour Sequential Organ Failure Assessment (SOFA) score, the Charlson Comorbidity Index, serum potassium, and whether the bloodstream infection was fungal.

That simplicity is the point. The catch, as the new study shows, is that a model’s performance in the population where it was built says little about how it will behave elsewhere, because healthcare systems, case mix and clinical practice differ across countries.

In internal validation on the MIMIC-IV data, the simplified five-variable model achieved an area under the receiver operating characteristic curve (AUC) of 0.776, only slightly below the 0.796 achieved by the full model.

The real test came in the external cohort: 285 ICU patients with bloodstream infection admitted to a tertiary teaching hospital in China. Discrimination held up reasonably well, with an AUC of 0.764, meaning the model still ranked patients by risk about as sharply as it had in the original US population. But calibration, the agreement between predicted probabilities and observed outcomes, was poor. The model systematically underestimated 30-day mortality in the Chinese cohort, with calibration-in-the-large greater than zero, meaning predicted risks were too low on average.

To fix this, the researchers applied local logistic recalibration, a low-resource statistical adjustment that refits the intercept and slope of the model to the new population without rebuilding it from scratch. The procedure brought the calibration-in-the-large and the calibration slope closer to their target values and reduced the Brier score, a combined measure of discrimination and calibration, to 0.182. In other words, the imported model needed only a modest statistical adjustment, not a full redevelopment, to become usable in the Chinese setting.

The authors are careful about the limits of that result. Because the recalibration was estimated and evaluated in the same Chinese cohort, the reported improvement may be optimistic, and the recalibrated model requires validation in independent healthcare systems before its performance can be considered established. The external cohort was also modest in size, at 285 patients, which constrains the precision of the performance estimates.

Even so, the study offers a practical message for hospitals considering imported prediction models. A parsimonious model developed on US data retained acceptable discrimination in this Chinese ICU cohort, but it showed important calibration drift, and local logistic recalibration offered a feasible way to correct it.

Subject of Research: Cross-national transportability and local recalibration of a 30-day mortality prediction model for ICU patients with bloodstream infection

Article Title: Cross-national transportability and local adaptation of a parsimonious 30-day mortality prediction model for ICU patients with bloodstream infection: from MIMIC-IV to a Chinese tertiary hospital

Article References: Zhu, Y., Song, W., Ren, Y., Wu, Y., Chen, X., Xu, J., & Zhu, Q. (2026). Cross-national transportability and local adaptation of a parsimonious 30-day mortality prediction model for ICU patients with bloodstream infection: from MIMIC-IV to a Chinese tertiary hospital. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-026-03929-9

Image Credits: AI Generated

DOI: 10.1186/s12911-026-03929-9

Keywords: ICU, bloodstream infection, mortality prediction, MIMIC-IV, external validation, calibration, recalibration, SOFA score, machine learning, China, prediction model transportability, Cross-national

News Source: Denise Maddox. (October 29, 2026). US-Derived ICU Mortality Model Holds Up in China, but Only After Recalibration. Scienmag.

Tags: bloodstream infectioncalibrationChinaCross-nationalexternal validationICUMachine LearningMIMIC-IVMortality Predictionprediction model transportabilityrecalibrationSOFA score
Share12Tweet7Share2ShareShareShare1

Related Posts

Systematic Review Maps How Honey Compounds Might Complement Liver Cancer Therapy

Systematic Review Maps How Honey Compounds Might Complement Liver Cancer Therapy

October 29, 2026
New Simulation Framework Stress-Tests AI Traffic Signals Against Real-World Incidents

New Simulation Framework Stress-Tests AI Traffic Signals Against Real-World Incidents

October 29, 2026

Machine Learning Flags Knowledge Gaps as Key Barrier to HIV Testing in Burkina Faso Pregnancy Care

October 29, 2026

Anesthesiology and Perioperative Sciences earns first impact factor of 7.5

October 29, 2026

POPULAR NEWS

  • Structured PLISSIT Counseling Improves Sexual Function in Middle-Aged Women, Trial Finds

    Structured PLISSIT Counseling Improves Sexual Function in Middle-Aged Women, Trial Finds

    29 shares
    Share 12 Tweet 7
  • CarbonBalance Framework Shifts AI Workloads to Cleaner Power, Cutting Simulated Emissions 41.6%

    29 shares
    Share 12 Tweet 7
  • Low Nutritional Risk Means Lower Remimazolam Doses for Sedation in Older Adults

    29 shares
    Share 12 Tweet 7
  • Rising seas could submerge a third of Amsterdam’s cycling network by 2100

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

LED Light and Methyl Jasmonate Boost Cepharanthine in Stephania Callus Cultures

Systematic Review Maps How Honey Compounds Might Complement Liver Cancer Therapy

New Simulation Framework Stress-Tests AI Traffic Signals Against Real-World Incidents

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.